579 * !
Thu, 8/6/2020,
3:00 PM -
4:50 PM
Virtual
30 Years Journey of Bayesian Adaptive Designs: From Bayesian Monitoring to Dynamic Treatment Regime — in Honor of Dr. Peter Thall’s 70th Birthday — Topic Contributed Papers
Biopharmaceutical Section , WNAR, Biometrics Section
Organizer(s): Ruitao LIN, The University of Texas MD Anderson Cancer Center
Chair(s): Ying Yuan, The University of Texas MD Anderson Cancer Center
3:05 PM
Subgroup-Specific Dose Finding in Phase I Clinical Trials Based on Time to Toxicity Allowing Adaptive Subgroup Combination
Andrew Genius Chapple, LSUHSC ; Peter F. Thall, M.D. Anderson Cancer Center
3:25 PM
An Adaptive Trial Design to Optimize Dose Schedule Regimes with Delayed Outcomes
Ruitao LIN, The University of Texas MD Anderson Cancer Center ; Ying Yuan, The University of Texas MD Anderson Cancer Center; Peter F. Thall, M.D. Anderson Cancer Center
3:45 PM
Robust Adaptive Incorporation of Historical Control Data in a Randomized Trial of External Cooling to Treat Septic Shock
Thomas Murray, University of Minnesota ; Peter F. Thall, M.D. Anderson Cancer Center; Frederique ARTHUR Schortgen, Groupe Hospitalier Henri-Mondor; Sarah ARTHUR Zohar, Centre de Recherche des Cordeliers; Sandrine Katsahian, Hopital Europen Georges-Pompidou
4:05 PM
Rethinking Prior Effective Sample Size
Satoshi Morita, Kyoto University
4:25 PM
Utilizing Bayesian Analysis for Probabilistic Decision Making in a Platform Clinical Trial
J. Wathen, Gilead Sciences
4:45 PM
Floor Discussion
